KEVIN BALTER: Open Payments
NPI 1568472520 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 16 payments from 9 companies in 2025. Trend: 2023 $1,040 · 2024 $2,732 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $131 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $120 |
| SI-BONE, INC. | 4 | $93 |
| ABBVIE INC. | 4 | $68 |
| Forte Bio-Pharma LLC | 2 | $29 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Indivior Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $14 |
Products named: INTELLIS ADAPTIVESTIM, JOURNAVX, BOTOX, PROLATE, HYMOVIS, SUBLOCADE, QUTENZA, UBRELVY.
Industry payments across NE — which companies pay providers there.
